Skip to main content

Articles

Original Research
Evolving Trends in Insulin Delivery: In Pursuit of Improvements in Diabetes Management
Stakeholder Perspective
Diabetes: An Epidemic of Disastrous Proportions
Read More
Original Research
Healthcare Costs Associated with Switching from Brand to Generic Levothyroxine
Stakeholder Perspective
Health Insurance Premium Increases for Large Employers
Read More
Practice Management
Pay-for-Performance Initiatives: Modest Benefits for Improving Healthcare Quality
Stakeholder Perspective
The Many Challenges of Pay-for-Performance Programs
Read More
Practice Management
Pharmacogenomics and Drug Development
Read More
Practice Management
First Anti-Inflammatory Generic Drug Promising New Therapy for Diabetes
Read More
FDA Approvals
The Cardiovascular Pipeline: ACC 2010 Features Late-Stage Drugs
Read More
Conference Highlights NCCN
NCCN Panel Debates the Economics of Cancer Care
Read More
Conference Highlights NCCN
PET Scans Not Recommended for Most Patients with Breast Cancer: Potential New Controversy in Breast Cancer Testing
Read More
Practice Management
Orphan Drug Pricing and Payer Management in the United States: Are We Approaching the Tipping Point?
Stakeholder Perspective
Orphan Drugs: The Potential Impact of Generic Biologics
Read More
Practice Management
Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care
Stakeholder Perspective
Diabetes Management Strategies: More Money Does Not Equal Better Care
Read More
Page 240 of 244
Results 2391 - 2400 of 2434